Clinical Trials Update: Nov. 3, 20102010-Nov-03
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study is for people with chronic hepatitis C, genotype 1. You must have had a liver biopsy less than 24 months ago without evidence of cirrhosis to qualify.
The research site is in Tamarac, Fla.
This study will evaluate the cardiovascular safety of febuxostat and allopurinol in people with gout and cardiovascular disease. Participants receive study medication and related medical care at no cost, and compensation for time and travel.
The research site is in Houston, Texas.
This study will evaluate the safety and tolerability of an investigational drug for moderate-to-severe chronic plaque psoriasis.
The research site is in Winston-Salem, N.C.
Copyright 2010 ClinicalConnection.com. All rights reserved.
Copyright © 2010
All rights reserved.